CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

医学 传统PCI 心肌梗塞 经皮冠状动脉介入治疗 心源性休克 内科学 心脏病学 氯吡格雷 替卡格雷 急性冠脉综合征 抗血栓
作者
Yukio Ozaki,Hironori Hara,Yoshinobu Onuma,Yuki Katagiri,Tetsuya Amano,Yoshio Kobayashi,Takashi Muramatsu,Hideki Ishii,Ken Kozuma,Nobuhiro Tanaka,Hitoshi Matsuo,Shiro Uemura,Kazushige Kadota,Yutaka Hikichi,Kenichi Tsujita,Junya Ako,Yoshihisa Nakagawa,Yoshihiro Morino,Ichiro Hamanaka,Nobuo Shiode
出处
期刊:Cardiovascular Intervention and Therapeutics [Springer Science+Business Media]
卷期号:37 (1): 1-34 被引量:115
标识
DOI:10.1007/s12928-021-00829-9
摘要

Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Interventional and Therapeutics (CVIT) society proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018. Updated guidelines for the management of AMI were published by the European Society of Cardiology (ESC) in 2017 and 2020. Major changes in the guidelines for STEMI patients included: (1) radial access and drug-eluting stents (DES) over bare-metal stents (BMS) were recommended as a Class I indication, (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. In 2020, updated guidelines for Non-ST-Elevation Myocardial Infarction (NSTEMI) patients, the followings were changed: (1) an early invasive strategy within 24 h is recommended in patients with NSTEMI as a Class I indication, (2) complete revascularization in NSTEMI patients without cardiogenic shock is considered as Class IIa recommendation, and (3) in patients with atrial fibrillation following a short period of triple antithrombotic therapy, dual antithrombotic therapy (e.g., DOAC and single oral antiplatelet agent preferably clopidogrel) is recommended, with discontinuation of the antiplatelet agent after 6 to 12 months. Furthermore, an aspirin-free strategy after PCI has been investigated in several trials those have started to show the safety and efficacy. The Task Force on Primary PCI of the CVIT group has now proposed the updated expert consensus document for the management of AMI focusing on procedural aspects of primary PCI in 2022 version.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
脾气暴躁的小兔完成签到,获得积分10
刚刚
迅速的小鸽子完成签到 ,获得积分10
1秒前
白给完成签到,获得积分10
2秒前
jingwei72完成签到 ,获得积分10
2秒前
一一完成签到 ,获得积分10
2秒前
Fledge完成签到,获得积分10
3秒前
陈星颖完成签到 ,获得积分10
4秒前
H里波特完成签到,获得积分10
4秒前
听安发布了新的文献求助10
4秒前
科研顺利完成签到 ,获得积分10
5秒前
子凡完成签到,获得积分10
5秒前
6秒前
量子星尘发布了新的文献求助10
7秒前
发nature完成签到 ,获得积分10
7秒前
8秒前
奶油兔兔兔完成签到 ,获得积分10
9秒前
Li完成签到,获得积分10
9秒前
隐形曼青应助QIQ采纳,获得10
9秒前
Xxxxzzz完成签到,获得积分10
10秒前
Phaladius完成签到 ,获得积分10
10秒前
猫九完成签到,获得积分10
10秒前
瘦瘦白薇完成签到 ,获得积分10
13秒前
华无心完成签到 ,获得积分10
13秒前
13秒前
机灵的安南完成签到 ,获得积分10
13秒前
明理的延恶完成签到 ,获得积分10
13秒前
yxsccjj完成签到 ,获得积分10
14秒前
量子星尘发布了新的文献求助10
15秒前
大个应助花生采纳,获得10
15秒前
15秒前
16秒前
玲儿5081完成签到 ,获得积分10
18秒前
儒雅的绿兰完成签到 ,获得积分10
18秒前
19秒前
陈峰琦发布了新的文献求助10
19秒前
风趣的从梦完成签到,获得积分10
19秒前
过时的砖头完成签到 ,获得积分10
19秒前
沐风应助平常的问儿采纳,获得20
19秒前
无脚鸟完成签到 ,获得积分10
21秒前
生生完成签到 ,获得积分10
22秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
Statistical Methods for the Social Sciences, Global Edition, 6th edition 600
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
The Insulin Resistance Epidemic: Uncovering the Root Cause of Chronic Disease  500
Walter Gilbert: Selected Works 500
An Annotated Checklist of Dinosaur Species by Continent 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3662377
求助须知:如何正确求助?哪些是违规求助? 3223209
关于积分的说明 9750464
捐赠科研通 2933030
什么是DOI,文献DOI怎么找? 1605861
邀请新用户注册赠送积分活动 758198
科研通“疑难数据库(出版商)”最低求助积分说明 734743